Document is current
Any future updates will be listed below
-
Authors
Borg, Alexander https://orcid.org/0000-0003-1013-4590
Jobs, Benjamin
Huss, Viking https://orcid.org/0000-0002-9764-6435
Gentline, Cidem
Espinosa, Fabricio https://orcid.org/0000-0001-6227-8209
Ruiz, Mini https://orcid.org/0000-0002-9910-8809
Edelbring, Samuel https://orcid.org/0000-0002-1110-0782
Georg, Carina https://orcid.org/0000-0001-8444-7624
Skantze, Gabriel https://orcid.org/0000-0002-8579-1790
Parodis, Ioannis https://orcid.org/0000-0002-4875-5395
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 28 August 2024
Accepted: 1 October 2024
First Online: 16 October 2024
Declarations
:
: Participation in the study was voluntary, and all participants provided written informed consent prior to inclusion. The Swedish Ethical Review Authority reviewed and approved the study protocol prior to initiation (registration number: 2022-04437-01).
: IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia, BMS, Elli Lilly, Gilead, GSK, Janssen, Novartis, Otsuka, and Roche. GS is a co-founder and Chief Scientist at Furhat Robotics. The other authors declare that they have no conflicts of interest.
